{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,29]],"date-time":"2026-03-29T00:48:05Z","timestamp":1774745285974,"version":"3.50.1"},"reference-count":37,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2005,11,1]],"date-time":"2005-11-01T00:00:00Z","timestamp":1130803200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2005,11,1]],"date-time":"2005-11-01T00:00:00Z","timestamp":1130803200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["atherosclerosis-journal.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Atherosclerosis"],"published-print":{"date-parts":[[2005,11]]},"DOI":"10.1016\/j.atherosclerosis.2005.03.003","type":"journal-article","created":{"date-parts":[[2005,4,16]],"date-time":"2005-04-16T07:28:33Z","timestamp":1113636513000},"page":"49-55","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Aspirin inhibits thrombin action on endothelial cells via up-regulation of aminopeptidase N\/CD13 expression"],"prefix":"10.1016","volume":"183","author":[{"given":"Midori","family":"Kato","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroyuki","family":"Azuma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masashi","family":"Akaike","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takahiko","family":"Iuchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ken-ichi","family":"Aihara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasumasa","family":"Ikeda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mitsunori","family":"Fujimura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomonori","family":"Yoshida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Yamaguchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shunji","family":"Hashizume","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshio","family":"Matsumoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.atherosclerosis.2005.03.003_bib1","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1016\/0140-6736(92)92619-Q","article-title":"Double-blind trial of aspirin in primary prevention of myocardial infarction in patients with stable chronic angina pectoris, The Swedish Angina Pectoris Aspirin Trial (SAPAT) Group","volume":"340","author":"Juul-Moller","year":"1992","journal-title":"Lancet"},{"key":"10.1016\/j.atherosclerosis.2005.03.003_bib2","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1136\/bmj.308.6921.81","article-title":"Collaborative overview of randomised trials of antiplatelet therapy. I. Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients","volume":"308","year":"1994","journal-title":"BMJ"},{"key":"10.1016\/j.atherosclerosis.2005.03.003_bib3","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1126\/science.8052854","article-title":"Inhibition of NF-kappa B by sodium salicylate and aspirin","volume":"265","author":"Kopp","year":"1994","journal-title":"Science"},{"key":"10.1016\/j.atherosclerosis.2005.03.003_bib4","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1126\/science.274.5291.1383","article-title":"Neuroprotection by aspirin and sodium salicylate through blockade of NF-kappa B activation","volume":"274","author":"Grilli","year":"1996","journal-title":"Science"},{"key":"10.1016\/j.atherosclerosis.2005.03.003_bib5","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1038\/23948","article-title":"The anti-inflammatory agents aspirin and salicylate inhibit the activity of I(kappa)B kinase-beta","volume":"396","author":"Yin","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.atherosclerosis.2005.03.003_bib6","doi-asserted-by":"crossref","first-page":"9962","DOI":"10.1074\/jbc.272.15.9962","article-title":"Inhibition of activator protein 1 activity and neoplastic transformation by aspirin","volume":"272","author":"Dong","year":"1997","journal-title":"J Biol Chem"},{"key":"10.1016\/j.atherosclerosis.2005.03.003_bib7","doi-asserted-by":"crossref","first-page":"26325","DOI":"10.1074\/jbc.272.42.26325","article-title":"Inhibition of ultraviolet B-induced activator protein-1 (AP-1) activity by aspirin in AP-1-luciferase transgenic mice","volume":"272","author":"Huang","year":"1997","journal-title":"J Biol Chem"},{"key":"10.1016\/j.atherosclerosis.2005.03.003_bib8","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1161\/01.RES.82.9.1016","article-title":"Aspirin increases ferritin synthesis in endothelial cells: a novel antioxidant pathway","volume":"82","author":"Oberle","year":"1998","journal-title":"Circ Res"},{"key":"10.1016\/j.atherosclerosis.2005.03.003_bib9","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1126\/science.1546322","article-title":"Effect of sodium salicylate on the human heat shock response","volume":"255","author":"Jurivich","year":"1992","journal-title":"Science"},{"key":"10.1016\/j.atherosclerosis.2005.03.003_bib10","doi-asserted-by":"crossref","first-page":"34111","DOI":"10.1074\/jbc.274.48.34111","article-title":"Aspirin reduces apolipoprotein(a) (apo(a)) production in human hepatocytes by suppression of apo(a) gene transcription","volume":"274","author":"Kagawa","year":"1999","journal-title":"J Biol Chem"},{"key":"10.1016\/j.atherosclerosis.2005.03.003_bib11","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0167-5699(98)01398-X","article-title":"CD13\u2014not just a marker in leukemia typing","volume":"20","author":"Riemann","year":"1999","journal-title":"Immunol Today"},{"key":"10.1016\/j.atherosclerosis.2005.03.003_bib12","doi-asserted-by":"crossref","first-page":"11713","DOI":"10.1021\/bi00162a007","article-title":"Thrombin receptor activating peptides: importance of the N-terminal serine and its ionization state as judged by pH dependence, nuclear magnetic resonance spectroscopy, and cleavage by aminopeptidase M","volume":"31","author":"Coller","year":"1992","journal-title":"Biochemistry"},{"key":"10.1016\/j.atherosclerosis.2005.03.003_bib13","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1056\/NEJM198602203140806","article-title":"The pathogenesis of atherosclerosis\u2014an update","volume":"314","author":"Ross","year":"1986","journal-title":"N Engl J Med"},{"key":"10.1016\/j.atherosclerosis.2005.03.003_bib14","doi-asserted-by":"crossref","first-page":"8412","DOI":"10.1073\/pnas.86.21.8412","article-title":"Role of platelets in smooth muscle cell proliferation and migration after vascular injury in rat carotid artery","volume":"86","author":"Fingerle","year":"1989","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.atherosclerosis.2005.03.003_bib15","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1172\/JCI116031","article-title":"Thrombin receptor expression in normal and atherosclerotic human arteries","volume":"90","author":"Nelken","year":"1992","journal-title":"J Clin Invest"},{"key":"10.1016\/j.atherosclerosis.2005.03.003_bib16","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1161\/01.CIR.102.3.332","article-title":"Thrombomodulin overexpression to limit neointima formation","volume":"102","author":"Waugh","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2005.03.003_bib17","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1161\/01.RES.0000050588.35034.3C","article-title":"Glucocorticoid excess induces superoxide production in vascular endothelial cells and elicits vascular endothelial dysfunction","volume":"92","author":"Iuchi","year":"2003","journal-title":"Circ Res"},{"key":"10.1016\/j.atherosclerosis.2005.03.003_bib18","doi-asserted-by":"crossref","first-page":"35798","DOI":"10.1074\/jbc.M404865200","article-title":"Disruption of nuclear vitamin D receptor gene causes enhanced thrombogenicity in mice","volume":"279","author":"Aihara","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1016\/j.atherosclerosis.2005.03.003_bib19","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1172\/JCI114015","article-title":"Human myeloid plasma membrane glycoprotein CD13 (gp150) is identical to aminopeptidase N","volume":"83","author":"Look","year":"1989","journal-title":"J Clin Invest"},{"key":"10.1016\/j.atherosclerosis.2005.03.003_bib20","doi-asserted-by":"crossref","first-page":"11999","DOI":"10.1016\/S0021-9258(18)99056-3","article-title":"Separate promoters control transcription of the human aminopeptidase N gene in myeloid and intestinal epithelial cells","volume":"266","author":"Shapiro","year":"1991","journal-title":"J Biol Chem"},{"key":"10.1016\/j.atherosclerosis.2005.03.003_bib21","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1007\/BF00121910","article-title":"Human melanoma invasion and metastasis enhancement by high expression of aminopeptidase N\/CD13","volume":"13","author":"Fujii","year":"1995","journal-title":"Clin Exp Metastasis"},{"key":"10.1016\/j.atherosclerosis.2005.03.003_bib22","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0021-9258(19)52451-6","article-title":"Protein measurement with the Folin phenol reagent","volume":"193","author":"Lowry","year":"1951","journal-title":"J Biol Chem"},{"key":"10.1016\/j.atherosclerosis.2005.03.003_bib23","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1182\/blood.V82.4.1052.1052","article-title":"Hematopoietic differentiation antigens that are membrane-associated enzymes: cutting is the key","volume":"82","author":"Shipp","year":"1993","journal-title":"Blood"},{"key":"10.1016\/j.atherosclerosis.2005.03.003_bib24","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1182\/blood.V97.3.652","article-title":"CD13\/APN is activated by angiogenic signals and is essential for capillary tube formation","volume":"97","author":"Bhagwat","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.atherosclerosis.2005.03.003_bib25","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1182\/blood-2002-05-1422","article-title":"The angiogenic regulator CD13\/APN is a transcriptional target of Ras signaling pathways in endothelial morphogenesis","volume":"101","author":"Bhagwat","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.atherosclerosis.2005.03.003_bib26","first-page":"231","article-title":"A low dose of aspirin (75mg\/day) lowers thrombin generation to a similar extent as a high dose of aspirin (300mg\/day)","volume":"11","author":"Undas","year":"2000","journal-title":"Blood Coagul Fibrinolysis"},{"key":"10.1016\/j.atherosclerosis.2005.03.003_bib27","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1055\/s-0037-1615701","article-title":"Treatment with simvastatin and low-dose aspirin depresses thrombin generation in patients with coronary heart disease and borderline-high cholesterol levels","volume":"85","author":"Musial","year":"2001","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.atherosclerosis.2005.03.003_bib28","doi-asserted-by":"crossref","first-page":"2423","DOI":"10.1182\/blood.V98.8.2423","article-title":"Blood coagulation at the site of microvascular injury: effects of low-dose aspirin","volume":"98","author":"Undas","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.atherosclerosis.2005.03.003_bib29","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1161\/01.CIR.91.7.1914","article-title":"Aspirin inhibits nuclear factor-kappa B mobilization and monocyte adhesion in stimulated human endothelial cells","volume":"91","author":"Weber","year":"1995","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2005.03.003_bib30","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/S0014-5793(96)01148-9","article-title":"Aspirin inhibits expression of the interleukin-1beta-inducible group II phospholipase A2","volume":"397","author":"Vervoordeldonk","year":"1996","journal-title":"FEBS Lett"},{"key":"10.1016\/j.atherosclerosis.2005.03.003_bib31","doi-asserted-by":"crossref","first-page":"4144","DOI":"10.1182\/blood.V86.11.4144.bloodjournal86114144","article-title":"Salicylates inhibit lipopolysaccharide-induced transcriptional activation of the tissue factor gene in human monocytic cells","volume":"86","author":"Oeth","year":"1995","journal-title":"Blood"},{"key":"10.1016\/j.atherosclerosis.2005.03.003_bib32","doi-asserted-by":"crossref","first-page":"1822","DOI":"10.1096\/fj.00-0843fje","article-title":"Aspirin inhibits NF-kappaB and protects from angiotensin II-induced organ damage","volume":"15","author":"Muller","year":"2001","journal-title":"FASEB J"},{"key":"10.1016\/j.atherosclerosis.2005.03.003_bib33","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1172\/JCI11559","article-title":"Prevention of fat-induced insulin resistance by salicylate","volume":"108","author":"Kim","year":"2001","journal-title":"J Clin Invest"},{"key":"10.1016\/j.atherosclerosis.2005.03.003_bib34","doi-asserted-by":"crossref","first-page":"24944","DOI":"10.1074\/jbc.M300423200","article-title":"Aspirin inhibits serine phosphorylation of insulin receptor substrate 1 in tumor necrosis factor-treated cells through targeting multiple serine kinases","volume":"278","author":"Gao","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1016\/j.atherosclerosis.2005.03.003_bib35","doi-asserted-by":"crossref","first-page":"49358","DOI":"10.1074\/jbc.M308071200","article-title":"CD13\/APN transcription is induced by RAS\/MAPK-mediated phosphorylation of Ets-2 in activated endothelial cells","volume":"278","author":"Petrovic","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1016\/j.atherosclerosis.2005.03.003_bib36","doi-asserted-by":"crossref","first-page":"20741","DOI":"10.1016\/S0021-9258(19)36844-9","article-title":"Substituting isoserine for serine in the thrombin receptor activation peptide SFLLRN confers resistance to aminopeptidase M-induced cleavage and inactivation","volume":"268","author":"Coller","year":"1993","journal-title":"J Biol Chem"},{"key":"10.1016\/j.atherosclerosis.2005.03.003_bib37","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1055\/s-0037-1616227","article-title":"Protease-activated receptors in vascular biology","volume":"86","author":"Coughlin","year":"2001","journal-title":"Thromb Haemost"}],"container-title":["Atherosclerosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915005001905?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915005001905?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,18]],"date-time":"2025-09-18T00:27:56Z","timestamp":1758155276000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021915005001905"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,11]]},"references-count":37,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2005,11]]}},"alternative-id":["S0021915005001905"],"URL":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2005.03.003","relation":{},"ISSN":["0021-9150"],"issn-type":[{"value":"0021-9150","type":"print"}],"subject":[],"published":{"date-parts":[[2005,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Aspirin inhibits thrombin action on endothelial cells via up-regulation of aminopeptidase N\/CD13 expression","name":"articletitle","label":"Article Title"},{"value":"Atherosclerosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2005.03.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2005 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}